161 related articles for article (PubMed ID: 5870987)
21. [Indications and contraindications of choleretic therapy].
Grossi F
Clin Ter; 1974; 70(2):108-9. PubMed ID: 4409826
[No Abstract] [Full Text] [Related]
22. [Combined effect of drugs on the extrasecretory function of the liver].
Skakun NP
Vrach Delo; 1967; 7():6-9. PubMed ID: 5621752
[No Abstract] [Full Text] [Related]
23. [Piprozoline in clinical trials (author's transl)].
Schleicher E
Arzneimittelforschung; 1977; 27(2b):520-6. PubMed ID: 326261
[TBL] [Abstract][Full Text] [Related]
24. [The chologenic and choleretic action of sorbitol].
Grancharov V
Vopr Pitan; 1973; 32(2):50-4. PubMed ID: 4782923
[No Abstract] [Full Text] [Related]
25. [Alpha-(1-hydroxy-4-phenylcyclohexyl)-butyric acid, a synthetic choleretic. Pharmacology, clinical aspects and review considerations on the experience of a few years of systematic use of the choleretic alone or in combination with other substances in hepatocholecystic syndromes].
Barbi G
Minerva Gastroenterol; 1966; 12(2):64-7. PubMed ID: 5960468
[No Abstract] [Full Text] [Related]
26. [Clinical experimentation with Régacholyl].
Rev Med Chir Mal Foie; 1970; 45(6):333-4. PubMed ID: 5502127
[No Abstract] [Full Text] [Related]
27. [Clinical experiences with felicur, a choleretic with a new pharmacological base].
DOPKE G
Munch Med Wochenschr; 1955 Dec; 97(52):1743-4. PubMed ID: 13288530
[No Abstract] [Full Text] [Related]
28. [Studies of the choleretic and liver-protective effects of the product, "Menabil Complex"].
Gheorghescu B; Steflea D; Jovin G; Suseanu I
Fiziol Norm Patol; 1973; 19(1):51-6. PubMed ID: 4266192
[No Abstract] [Full Text] [Related]
29. [Clinical study of a synthetic choleretic: alpha-(1-hydroxy-4-phonyl-cyclohexyl)-butyric acid (MG 4833)].
Montemartini C; Fontana S; Calderoni AG
Clin Ter; 1967 Jul; 42(2):121-39. PubMed ID: 5598371
[No Abstract] [Full Text] [Related]
30. [Studies on the potency of action of several choleretics].
Mörsdorf K; Wolf G
Dtsch Med J; 1966 May; 17(10):303-6. PubMed ID: 5985421
[No Abstract] [Full Text] [Related]
31. Achillea millefolium L. s.l. revisited: recent findings confirm the traditional use.
Benedek B; Kopp B
Wien Med Wochenschr; 2007; 157(13-14):312-4. PubMed ID: 17704978
[TBL] [Abstract][Full Text] [Related]
32. [Double-blind clinical evaluation of choleretic agents in patients with chronic liver disease and cholestasis syndromes].
Alkabes M; Ancona A; Palmieri R; Palmieri G; Zambruno E
Clin Ter; 1980 Dec; 95(6):637-54. PubMed ID: 7011665
[No Abstract] [Full Text] [Related]
33. [Current status of hepatic and biliary drug therapy. II].
Donatelli L; Marmo E
Clin Ter; 1976 Mar; 76(6):495-513. PubMed ID: 797505
[No Abstract] [Full Text] [Related]
34. [Treatment of biliary tract diseases with Felwiten].
Gonciarz Z
Pol Tyg Lek; 1971 Jul; 26(28):1084-6. PubMed ID: 5096682
[No Abstract] [Full Text] [Related]
35. [Therapeutic properties of the cholagogue preparation flastapiol in biliary tract diseases in children].
Shmorgun SS; Zinchenko TV; Maksiutina NP
Pediatr Akus Ginekol; 1974; (2):22-4. PubMed ID: 4438009
[No Abstract] [Full Text] [Related]
36. [Cholelithin therapy of angiocholecystites and dyskinesias of bile ducts in children].
Shmorgun SS; Cherniavskaia VG
Pediatr Akus Ginekol; 1967; 2():27-9. PubMed ID: 5610524
[No Abstract] [Full Text] [Related]
37. [On a combination of a synthetic choleretic and a "mixed" spasmolytic with vitamins B-I and PP, in the therapy of some hepatobiliary diseases. Clinical study].
ABBONA C; GATTO PL
Minerva Med; 1962 May; 53():1486-91. PubMed ID: 13858818
[No Abstract] [Full Text] [Related]
38. [Study of the choleretic value of ragacholyl in man].
Rev Med Chir Mal Foie; 1971; 46(1):45-52. PubMed ID: 5580580
[No Abstract] [Full Text] [Related]
39. [Cholagogue and choleretic action of mineral waters].
Messina B
Clin Ter; 1974; 70(2):110-2. PubMed ID: 4408868
[No Abstract] [Full Text] [Related]
40. [Clinico-experimental study on a new substance with choleretic action (1-phenyl-1-hydroxy-n-pentane) associated with a spasmolytic having double atropine- and papaverine-like action in patients with hepatobiliary diseases].
VANCINI B
Minerva Med; 1962 May; 53():1478-86. PubMed ID: 13924674
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
